| First Author | Zhang J | Year | 2017 |
| Journal | Nat Commun | Volume | 8 |
| Pages | 13732 | PubMed ID | 28054552 |
| Mgi Jnum | J:243445 | Mgi Id | MGI:5908498 |
| Doi | 10.1038/ncomms13732 | Citation | Zhang J, et al. (2017) c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. Nat Commun 8:13732 |
| abstractText | It is well known that c-Src has important roles in tumorigenesis. However, it remains unclear whether c-Src contributes to metabolic reprogramming. Here we find that c-Src can interact with and phosphorylate hexokinases HK1 and HK2, the rate-limiting enzymes in glycolysis. Tyrosine phosphorylation dramatically increases their catalytic activity and thus enhances glycolysis. Mechanistically, c-Src phosphorylation of HK1 at Tyr732 robustly decreases its Km and increases its Vmax by disrupting its dimer formation. Mutation in c-Src phosphorylation site of either HK1 or HK2 remarkably abrogates the stimulating effects of c-Src on glycolysis, cell proliferation, migration, invasion, tumorigenesis and metastasis. Due to its lower Km for glucose, HK1 rather than HK2 is required for tumour cell survival when glucose is scarce. Importantly, HK1-Y732 phosphorylation level remarkably correlates with the incidence and metastasis of various clinical cancers and may serve as a marker to predict metastasis risk of primary cancers. |
